FindTrial
Sign In

A study research major complication after radiofrequency ablation of recurrent liver cancer

Risk factors analysis and establishment of prediction model of major complication after radiofrequency ablation in recurrent hepatocellular carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034526
Enrollment
Unknown
Registered
2020-07-08
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recurrent hepatocellular carcinoma

Interventions

postoperative complication group:Nil
without postoperative complication group:Nil

Sponsors

Shandong Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Recurrent HCC patients who received RFA. (2) Aged >18 years. (3) Single tumor diameter <= 5 cm or multiple tumor ,tumor number <= 3 and each diameter <= 3cm.

Exclusion criteria

Exclusion criteria: (1) Laparoscopic RFA or intraoperative RFA. (2) Extra-hepatic tumor metastasis or with portal vein tumor thrombus. (3) With other tumors.

Design outcomes

Primary

MeasureTime frame
postoperative complication;—

Secondary

MeasureTime frame
liver function;Oncological characteristics;kidney function;Parameters of radiofrequency ablation;—

Countries

China

Contacts

Public ContactQiang Zhu

Shandong Provincial Hospital

zhuqiang@medmail.com.cn+86 15168887780

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026